Mirum Pharmaceuticals Inc (MIRM)
40.48
+0.08
(+0.20%)
USD |
NASDAQ |
Nov 04, 16:00
40.48
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Max Drawdown (5Y): 63.78% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 63.78% |
| September 30, 2024 | 63.78% |
| August 31, 2024 | 63.78% |
| July 31, 2024 | 63.78% |
| June 30, 2024 | 63.78% |
| May 31, 2024 | 63.78% |
| April 30, 2024 | 63.78% |
| March 31, 2024 | 63.78% |
| February 29, 2024 | 63.78% |
| January 31, 2024 | 63.78% |
| December 31, 2023 | 63.78% |
| November 30, 2023 | 63.78% |
| October 31, 2023 | 63.78% |
| September 30, 2023 | 63.78% |
| August 31, 2023 | 63.78% |
| July 31, 2023 | 63.78% |
| June 30, 2023 | 63.78% |
| May 31, 2023 | 63.78% |
| April 30, 2023 | 63.78% |
| March 31, 2023 | 63.78% |
| February 28, 2023 | 63.78% |
| January 31, 2023 | 63.78% |
| December 31, 2022 | 63.78% |
| November 30, 2022 | 63.78% |
| October 31, 2022 | 63.78% |
| Date | Value |
|---|---|
| September 30, 2022 | 63.78% |
| August 31, 2022 | 63.78% |
| July 31, 2022 | 63.78% |
| June 30, 2022 | 63.78% |
| May 31, 2022 | 63.78% |
| April 30, 2022 | 63.78% |
| March 31, 2022 | 63.78% |
| February 28, 2022 | 63.78% |
| January 31, 2022 | 63.78% |
| December 31, 2021 | 63.78% |
| November 30, 2021 | 63.78% |
| October 31, 2021 | 63.78% |
| September 30, 2021 | 63.78% |
| August 31, 2021 | 63.78% |
| July 31, 2021 | 63.78% |
| June 30, 2021 | 63.78% |
| May 31, 2021 | 63.78% |
| April 30, 2021 | 63.78% |
| March 31, 2021 | 63.78% |
| February 28, 2021 | 63.78% |
| January 31, 2021 | 63.78% |
| December 31, 2020 | 63.78% |
| November 30, 2020 | 63.78% |
| October 31, 2020 | 63.78% |
| September 30, 2020 | 63.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
53.69%
Minimum
Nov 2019
63.78%
Maximum
Mar 2020
63.11%
Average
63.78%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Cytokinetics Inc | 55.71% |
| MannKind Corp | 97.67% |
| TG Therapeutics Inc | 93.19% |
| Ocugen Inc | 99.95% |
| Rhythm Pharmaceuticals Inc | 92.10% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 22.51 |
| Beta (5Y) | 1.164 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 66.71% |
| Historical Sharpe Ratio (5Y) | 0.5625 |
| Historical Sortino (5Y) | 1.398 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.04% |